ArticleBiomedicines2023

Confirmation of CD19+ B-Lymphocyte Depletion Prior to Intake of the Second Dose of Ocrelizumab in Multiple Sclerosis Patients.

Marija Radmilo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.